BioPorto Past Earnings Performance
Past criteria checks 0/6
BioPorto's earnings have been declining at an average annual rate of -11%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been growing at an average rate of 1.7% per year.
Key information
-11.0%
Earnings growth rate
5.1%
EPS growth rate
Biotechs Industry Growth | 11.5% |
Revenue growth rate | 1.7% |
Return on equity | -135.8% |
Net Margin | -245.7% |
Next Earnings Update | 01 Aug 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How BioPorto makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 23 | 31 | -75 | 65 | 33 |
31 Dec 22 | 29 | -76 | 63 | 35 |
30 Sep 22 | 27 | -68 | 58 | 36 |
30 Jun 22 | 27 | -62 | 56 | 33 |
31 Mar 22 | 25 | -59 | 51 | 30 |
31 Dec 21 | 24 | -57 | 50 | 30 |
30 Sep 21 | 25 | -54 | 48 | 27 |
30 Jun 21 | 24 | -60 | 48 | 29 |
31 Mar 21 | 25 | -62 | 48 | 31 |
31 Dec 20 | 23 | -62 | 49 | 28 |
30 Sep 20 | 22 | -64 | 45 | 30 |
30 Jun 20 | 24 | -68 | 54 | 29 |
31 Mar 20 | 25 | -69 | 59 | 25 |
31 Dec 19 | 27 | -70 | 62 | 25 |
30 Sep 19 | 29 | -61 | 63 | 22 |
30 Jun 19 | 28 | -51 | 55 | 16 |
31 Mar 19 | 27 | -43 | 47 | 17 |
31 Dec 18 | 26 | -38 | 41 | 19 |
30 Sep 18 | 24 | -38 | 37 | 22 |
30 Jun 18 | 25 | -36 | 34 | 25 |
31 Mar 18 | 24 | -35 | 33 | 24 |
31 Dec 17 | 25 | -32 | 33 | 22 |
30 Sep 17 | 25 | -29 | 57 | 25 |
30 Jun 17 | 23 | -27 | 49 | 18 |
31 Mar 17 | 21 | -26 | 40 | 14 |
31 Dec 16 | 21 | -23 | 31 | 10 |
30 Sep 16 | 20 | -21 | 18 | 10 |
30 Jun 16 | 20 | -16 | 18 | 10 |
31 Mar 16 | 21 | -12 | 18 | 10 |
31 Dec 15 | 20 | -11 | 18 | 10 |
30 Sep 15 | 20 | -11 | 20 | 9 |
30 Jun 15 | 19 | -12 | 20 | 9 |
31 Mar 15 | 18 | -13 | 20 | 9 |
31 Dec 14 | 19 | -13 | 20 | 9 |
30 Sep 14 | 18 | -15 | 19 | 10 |
30 Jun 14 | 19 | -19 | 19 | 10 |
31 Mar 14 | 18 | -20 | 19 | 10 |
31 Dec 13 | 17 | -22 | 19 | 10 |
30 Sep 13 | 17 | -20 | 15 | 10 |
30 Jun 13 | 16 | -17 | 15 | 10 |
31 Mar 13 | 16 | -16 | 15 | 10 |
31 Dec 12 | 18 | -15 | 15 | 10 |
30 Sep 12 | 17 | -16 | 15 | 8 |
30 Jun 12 | 17 | -16 | 15 | 8 |
Quality Earnings: BIOPOC is currently unprofitable.
Growing Profit Margin: BIOPOC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOPOC is unprofitable, and losses have increased over the past 5 years at a rate of 11% per year.
Accelerating Growth: Unable to compare BIOPOC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOPOC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-26.8%).
Return on Equity
High ROE: BIOPOC has a negative Return on Equity (-135.75%), as it is currently unprofitable.